Cargando…
Glucagon-Like Peptide-1: A Promising Agent for Cardioprotection During Myocardial Ischemia
Glucagon-like peptide-1-(7-36) amide (GLP-1) is a human incretin hormone responsible for the release of insulin in response to food. Pre-clinical and human physiological studies have demonstrated cardioprotection from ischemia-reperfusion injury. It can reduce infarct size, ischemic left ventricular...
Autores principales: | Giblett, Joel P., Clarke, Sophie J., Dutka, David P., Hoole, Stephen P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113423/ https://www.ncbi.nlm.nih.gov/pubmed/30167515 http://dx.doi.org/10.1016/j.jacbts.2016.03.011 |
Ejemplares similares
-
Glucagon-like peptide-1 derived cardioprotection does not utilize a KATP-channel dependent pathway: mechanistic insights from human supply and demand ischemia studies
por: Giblett, Joel P., et al.
Publicado: (2016) -
Optimising cardioprotection during myocardial ischaemia: targeting potential intracellular pathways with glucagon-like peptide-1
por: Clarke, Sophie J, et al.
Publicado: (2014) -
Glucagon-Like Peptide-1–Mediated Cardioprotection Does Not Reduce Right Ventricular Stunning and Cumulative Ischemic Dysfunction After Coronary Balloon Occlusion
por: Giblett, Joel P., et al.
Publicado: (2019) -
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
por: Michos, Erin D., et al.
Publicado: (2023) -
The cardioprotective power of leaves
por: Dudzińska, Dominika, et al.
Publicado: (2015)